Parkwood LLC’s GSK GSK Stock Holding History

Parkwood LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-38,868	Closed	-$2.05M	–	475
2017 Q1	$2.05M	Sell	38,868 -12,212	-24%	-$620K	0.29%	76
2016 Q4	$2.46M	Buy	51,080 +5,176	+11%	+$256K	0.38%	66
2016 Q3	$2.48M	Sell	45,904 -2,182	-5%	-$120K	0.37%	68
2016 Q2	$2.6M	Sell	48,086 -5,234	-10%	-$276K	0.44%	62
2016 Q1	$2.7M	Buy	53,320 +44,081	+477%	+$2.2M	0.46%	48
2015 Q4	$466K	Buy	9,239 +839	+10%	+$42.8K	0.07%	265
2015 Q3	$404K	Buy	+8,400	New	+$437K	0.07%	220

Other funds holding GSK

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Royal Bank of Canada

Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return